Type of Cancer
Genito-Urinary
Phase
Division (Location)
Study ID
NCT#
Brief Description
Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.